These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26051234)

  • 1. New scale assesses benefits of cancer medicines.
    Bagcchi S
    Lancet Oncol; 2015 Jul; 16(7):e316. PubMed ID: 26051234
    [No Abstract]   [Full Text] [Related]  

  • 2. Despite criticism of the FDA review process, new cancer drugs reach patients sooner in the United States than in Europe.
    Roberts SA; Allen JD; Sigal EV
    Health Aff (Millwood); 2011 Jul; 30(7):1375-81. PubMed ID: 21680577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Learning from exceptional drug responders.
    Mullard A
    Nat Rev Drug Discov; 2014 Jun; 13(6):401-2. PubMed ID: 24875081
    [No Abstract]   [Full Text] [Related]  

  • 4. American society of clinical oncology--41st annual meeting. Immunology.
    Shah S; Yager N
    IDrugs; 2005 Jul; 8(7):528-30. PubMed ID: 15973554
    [No Abstract]   [Full Text] [Related]  

  • 5. American society of clinical oncology - 45th annual meeting. Part 1.
    Gale S
    IDrugs; 2009 Jul; 12(7):401-3. PubMed ID: 19579154
    [No Abstract]   [Full Text] [Related]  

  • 6. American society of clinical oncology - 45th annual meeting. Part 2.
    Lakeram M; Kibble A
    IDrugs; 2009 Jul; 12(7):404-8. PubMed ID: 19579155
    [No Abstract]   [Full Text] [Related]  

  • 7. Summary of presentations from the 46th annual meeting of the American Society Of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer.
    Morgensztern D; Pennell NA; Subramanian J; Govindan R
    Clin Lung Cancer; 2011 Mar; 12(2):94-9. PubMed ID: 21550555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CC-5013 (Celgene).
    Mitsiades CS; Mitsiades N
    Curr Opin Investig Drugs; 2004 Jun; 5(6):635-47. PubMed ID: 15242253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One community. The B. Chevalier Lecture, held at the EORTC New Drugs Meeting, Lugano, Switzerland, 19-21 June 1997.
    Wittes RE; Yoder O
    Ann Oncol; 1998 Mar; 9(3):251-4. PubMed ID: 9602257
    [No Abstract]   [Full Text] [Related]  

  • 10. The erosion of research integrity: the need for culture change.
    Ellis LM
    Lancet Oncol; 2015 Jul; 16(7):752-4. PubMed ID: 26149871
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of the National Cancer Institute in drug development.
    Doroshow J
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):257-8. PubMed ID: 16166997
    [No Abstract]   [Full Text] [Related]  

  • 12. Marking off new territory in the search for anticancer compounds: epigenetic mechanisms add complexity and promise to cancer research efforts.
    Nelson B
    Cancer Cytopathol; 2012 Jun; 120(3):143-4. PubMed ID: 22692980
    [No Abstract]   [Full Text] [Related]  

  • 13. American society of clinical oncology--41st annual meeting.
    Shah S; Yager N
    IDrugs; 2005 Jul; 8(7):525-7. PubMed ID: 15973553
    [No Abstract]   [Full Text] [Related]  

  • 14. Epothilone D (Kosan/Roche).
    Kolman A
    Curr Opin Investig Drugs; 2004 Jun; 5(6):657-67. PubMed ID: 15242255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slow start to phase 0 as researchers debate value.
    Twombly R
    J Natl Cancer Inst; 2006 Jun; 98(12):804-6. PubMed ID: 16788150
    [No Abstract]   [Full Text] [Related]  

  • 16. American Society of Clinical Oncology--41st annual meeting. Drug highlights II.
    Shah S; Yager N
    IDrugs; 2005 Jul; 8(7):534-6. PubMed ID: 15973556
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hospital network in pediatric oncology].
    Doz F
    Arch Pediatr; 2006 Jun; 13(6):635-7. PubMed ID: 16697587
    [No Abstract]   [Full Text] [Related]  

  • 18. [New therapeutic strategies in oncology].
    Bohuon C
    Ann Pharm Fr; 2010 Jul; 68(4):203-4. PubMed ID: 20637352
    [No Abstract]   [Full Text] [Related]  

  • 19. The era of cancer discovery.
    Cantley LC; Baselga J
    Cancer Discov; 2011 Jun; 1(1):1. PubMed ID: 22586302
    [No Abstract]   [Full Text] [Related]  

  • 20. When are "positive" clinical trials in oncology truly positive?
    Ocana A; Tannock IF
    J Natl Cancer Inst; 2011 Jan; 103(1):16-20. PubMed ID: 21131576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.